HIGH EXPRESSION OF BCL-2 PREDICTS POOR OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH CHOP-BASED CHEMOTHERAPY

被引:0
|
作者
Lee, H. W. [1 ]
Choi, J. -H. [1 ]
Ahn, M. S. [1 ]
Kang, S. Y. [1 ]
Jeong, S. H. [1 ]
Park, J. S. [1 ]
Han, J. H. [2 ]
Kim, J. H. [2 ]
机构
[1] Ajou Univ Hosp, Dept Hematol Oncol, Suwon, South Korea
[2] Ajou Univ Hosp, Dept Pathol, Suwon, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:105 / 106
页数:2
相关论文
共 50 条
  • [31] High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
    Cardesa-Salzmann, Teresa M.
    Colomo, Luis
    Gutierrez, Gonzalo
    Chan, Wing C.
    Weisenburger, Dennis
    Climent, Fina
    Gonzalez-Barca, Eva
    Mercadal, Santiago
    Arenillas, Leonor
    Serrano, Sergio
    Tubbs, Ray
    Delabie, Jan
    Gascoyne, Randy D.
    Connors, Joseph M.
    Mate, Jose L.
    Rimsza, Lisa
    Braziel, Rita
    Rosenwald, Andreas
    Lenz, Georg
    Wright, George
    Jaffe, Elaine S.
    Staudt, Louis
    Jares, Pedro
    Lopez-Guillermo, Armando
    Campo, Elias
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 996 - 1001
  • [32] Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma
    Childress, M. O.
    Ramos-Vara, J. A.
    Ruple, A.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : E159 - E168
  • [33] THE INTERNATIONAL STAGING SYSTEM PREDICTS OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP
    Feng, Ru
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S62 - S62
  • [34] Results of CHOP chemotherapy for diffuse large B-cell lymphoma
    Hallack Neto, A. E.
    Pereira, J.
    Beitler, B.
    Chamone, D. A. F.
    Llacer, P. D.
    Dulley, F. L.
    Macedo, M. C. M. A.
    Chaoubah, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (10) : 1315 - 1322
  • [35] MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
    Perry, Anamarija M.
    Alvarado-Bernal, Yuridia
    Laurini, Javier A.
    Smith, Lynette M.
    Slack, Graham W.
    Tan, King L.
    Sehn, Laurie H.
    Fu, Kai
    Aoun, Patricia
    Greiner, Timothy C.
    Chan, Wing C.
    Bierman, Philip J.
    Bociek, Robert G.
    Armitage, James O.
    Vose, Julie M.
    Gascoyne, Randy D.
    Weisenburger, Dennis D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 382 - 391
  • [36] Coexpression of MYC and BCL2 Protein in Diffuse Large B-Cell Lymphoma Predicts a Poor Outcome in Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
    Low, Lawrence
    Song, Joo
    Mei, Matthew
    Krishnan, Amrita
    Nademanee, Auayporn
    Popplewell, Leslie
    Chen, Robert
    Spielberger, Ricardo
    Cai, Ji-lian
    Chen, Yuan-Yuan
    Gaal, Karl
    Aoun, Patricia
    Weisenburger, Dennis
    Kim, Young
    Zumel, Sean
    MODERN PATHOLOGY, 2015, 28 : 361A - 361A
  • [37] The Expression of CD44v6 Predicts Poor Outcome in Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP
    Wei, Yongqiang
    Xie, Muchen
    Huang, Fen
    Wei, Xiaolei
    Jing, Hui
    Hao, Xiaoxiao
    Zeng, Hong
    Zhou, Qinjun
    Xu, Linwei
    Feng, Ru
    BLOOD, 2014, 124 (21)
  • [38] Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells
    Jovanovic, Maja Perunicic
    Jakovic, Ljubomir
    Bogdanovic, Andrija
    Markovic, Olivera
    Martinovic, Vesna Cemerikic
    Mihaljevic, Biljana
    VOJNOSANITETSKI PREGLED, 2009, 66 (09) : 738 - 743
  • [39] Rituximab, bevacizumab (avastin) and CHOP (RA-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL).
    Ganjoo, KN
    Gordon, L
    Robertson, MJ
    Horning, SJ
    BLOOD, 2004, 104 (11) : 389A - 389A
  • [40] CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma
    Wilson, Kenneth S.
    Sehn, Laurie H.
    Berry, Brian
    Chhanabhai, Mukesh
    Fitzgerald, Catherine A.
    Gill, Karamjit K.
    Klasa, Richard
    Skinnider, Brian
    Sutherland, Judy
    Connors, Joseph M.
    Gascoyne, Randy D.
    LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1102 - 1109